Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9350
+0.0468 (5.27%)
At close: Sep 5, 2025, 4:00 PM
0.9299
-0.0051 (-0.55%)
After-hours: Sep 5, 2025, 7:47 PM EDT

Outlook Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2016 - 2020
Net Income
-43.44-75.37-58.98-66.05-53.16-35.24
Upgrade
Depreciation & Amortization
0.120.110.040.20.260.55
Upgrade
Asset Writedown & Restructuring Costs
-----0.53
Upgrade
Loss (Gain) on Equity Investments
0.120.10.010.050.05-
Upgrade
Stock-Based Compensation
8.485.395.557.714.892.81
Upgrade
Other Operating Activities
-29.083.995.653.10.790.83
Upgrade
Change in Accounts Receivable
-1.75-----
Upgrade
Change in Accounts Payable
4.171.393.081.3-0.2-1.49
Upgrade
Change in Income Taxes
------0
Upgrade
Change in Other Net Operating Assets
9.08-4.411.67-2.98-6.880.22
Upgrade
Operating Cash Flow
-56.43-68.79-42.97-56.67-54.25-31.79
Upgrade
Investment in Securities
------0.9
Upgrade
Investing Cash Flow
------0.9
Upgrade
Long-Term Debt Issued
--3010100.9
Upgrade
Long-Term Debt Repaid
--0-10.23-12.32-3.69-0.26
Upgrade
Net Debt Issued (Repaid)
-0.72-019.77-2.326.310.64
Upgrade
Issuance of Common Stock
34.0360.3330.0262.5149.936.57
Upgrade
Other Financing Activities
---0.82-0.6-0.01-
Upgrade
Financing Cash Flow
33.3160.3348.9759.5956.1937.21
Upgrade
Net Cash Flow
-23.12-8.4662.921.944.52
Upgrade
Free Cash Flow
-56.43-68.79-42.97-56.67-54.25-31.79
Upgrade
Free Cash Flow Margin
-3748.97%-----
Upgrade
Free Cash Flow Per Share
-1.95-3.71-3.44-5.34-7.11-8.76
Upgrade
Cash Interest Paid
-0.481.161.560.050.91
Upgrade
Levered Free Cash Flow
-28.48-44.3-24.26-32.53-35.62-17.11
Upgrade
Unlevered Free Cash Flow
-28.05-42.33-22.68-31.6-35.03-16.01
Upgrade
Change in Working Capital
7.37-3.024.75-1.68-7.08-1.27
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q